We are live on
!
Find out more
CCM
Cadence Capital Management Portfolio holdings
AUM
$415M
1-Year Est. Return
11.01%
This Fund
S&P 500
This Quarter
Est. Return
+5.16%
1 Year Est. Return
-11.01%
3 Year Est. Return
+0.72%
5 Year Est. Return
+39.08%
10 Year Est. Return
–
AUM
$1.37B
AUM Growth
+$44.5M
(+3.4%)
Cap. Flow
-$9.6M
Cap. Flow
% of AUM
-0.7%
Top 10 Holdings %
Top 10 Hldgs %
10.12%
Holding
687
New
99
Increased
230
Reduced
280
Closed
72
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$12.2M |
| 2 |
Gilead Sciences
GILD
|
+$11.6M |
| 3 |
ConocoPhillips
COP
|
+$5.98M |
| 4 |
Morgan Stanley
MS
|
+$5.54M |
| 5 |
Capri Holdings
CPRI
|
+$3.95M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$11.9M |
| 2 |
American International
AIG
|
+$11.1M |
| 3 |
Texas Instruments
TXN
|
+$9.03M |
| 4 |
Prudential Financial
PRU
|
+$7.31M |
| 5 |
General Motors
GM
|
+$6.08M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.46% |
| 2 | Industrials | 14.03% |
| 3 | Technology | 11.99% |
| 4 | Healthcare | 11.73% |
| 5 | Consumer Staples | 11.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Pathward Financial
CASH
$1.88B
| $884K | 0.06% |
43,749
-11,166
| -20% | -$213K |
|
|
LDR
352
DELISTED
Landauer Inc
LDR
| $881K | 0.06% |
19,797
-138
| -0.7% | -$6.08K |
|
353
Watsco Inc
WSO
$13.7B
| $880K | 0.06% |
6,248
+1,456
| +30% | +$209K |
|
|
CCRN
354
DELISTED
Cross Country Healthcare
CCRN
| $875K | 0.06% |
74,305
-523
| -0.7% | -$6.89K |
|
355
Stoneridge
SRI
$211M
| $870K | 0.06% |
47,297
-339
| -0.7% | -$5.84K |
|
356
Flowers Foods
FLO
$1.57B
| $868K | 0.06% |
57,432
+10,416
| +22% | +$173K |
|
357
Crawford & Co Class B
CRD.B
$573M
| $855K | 0.06% |
75,356
-24,064
| -24% | -$265K |
|
|
GGP
358
DELISTED
GGP Inc.
GGP
| $852K | 0.06% |
30,856
-1,018
| -3% | -$30.4K |
|
|
BRCD
359
DELISTED
Brocade Communications Systems, Inc. NEW
BRCD
| $850K | 0.06% |
92,144
+18,784
| +26% | +$175K |
|
|
NVEE
360
DELISTED
NV5 Global
NVEE
| $843K | 0.06% |
104,388
-756
| -0.7% | -$5.98K |
|
361
FormFactor
FORM
$8.94B
| $841K | 0.06% |
+77,500
| New | +$780K |
|
|
EXA
362
DELISTED
EXA Corporation
EXA
| $839K | 0.06% |
+52,280
| New | +$786K |
|
363
Exelon
EXC
$47.1B
| $830K | 0.06% |
34,942
+16,853
| +93% | +$423K |
|
364
ICU Medical
ICUI
$4.16B
| $830K | 0.06% |
6,570
| – | – |
|
|
STRR
365
DELISTED
Star Equity Holdings
STRR
| $829K | 0.06% |
3,252
-22
| -0.7% | -$5.8K |
|
366
Glaukos
GKOS
$10.1B
| $827K | 0.06% |
21,920
+12,260
| +127% | +$406K |
|
367
AXIS Capital
AXS
$7.61B
| $825K | 0.06% |
15,181
-847
| -5% | -$46.7K |
|
368
8x8 Inc
EGHT
$333M
| $825K | 0.06% |
53,459
-30,773
| -37% | -$438K |
|
369
Forrester Research
FORR
$226M
| $822K | 0.06% |
21,131
+10,128
| +92% | +$401K |
|
370
Realty Income
O
$58.5B
| $822K | 0.06% |
12,677
+67
| +0.5% | +$4.42K |
|
371
Synchrony
SYF
$25.8B
| $817K | 0.06% |
29,168
+14,400
| +98% | +$396K |
|
372
GameStop
GME
$8.53B
| $810K | 0.06% |
117,448
+32,412
| +38% | +$236K |
|
|
DFS
373
DELISTED
Discover Financial Services
DFS
| $809K | 0.06% |
14,302
+6,519
| +84% | +$373K |
|
374
Masco
MAS
$15.2B
| $808K | 0.06% |
23,554
-1,071
| -4% | -$37K |
|
375
Universal Electronics
UEIC
$60.6M
| $801K | 0.06% |
10,763
-74
| -0.7% | -$5.57K |
|
Similar funds
MGAI
FA
LWS
VCP
AIM
F
CPF
IA
Cadence Capital Management's Q3 2016 Portfolio in Review
As of Q3 2016, Cadence Capital Management held 687 positions worth $1.37B, up 3.4% from $1.33B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Cadence Capital Management's Q3 2016 filing shows 99 new, 230 increased, 280 reduced and 72 closed positions. Its largest new stake was Bristol-Myers Squibb: 190,283 shares worth $10.3M. The largest sale was Apple, an estimated $11.9M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 16% a quarter earlier, followed by Industrials and Technology.
- Cadence Capital Management's largest Q3 2016 buy was Bristol-Myers Squibb: 190,283 shares worth $10.3M.
- Cadence Capital Management added most to Gilead Sciences in Q3 2016, an estimated $11.6M increase.
- Cadence Capital Management's biggest Q3 2016 reduction was Apple, cutting an estimated $11.9M.
- Cadence Capital Management fully exited American International in Q3 2016, selling an estimated $11.1M.
- Cadence Capital Management's ten largest holdings make up 10% of its $1.37B portfolio in Q3 2016.
- Cadence Capital Management opened 99 new positions and closed 72 in Q3 2016.
- Cadence Capital Management's portfolio value rose 3.4% quarter-over-quarter to $1.37B.
Based on Cadence Capital Management's 13F filing for Q3 2016, filed 10 Nov 2016.